{"count": 2, "results": [{"_id": "37695982", "pmid": 37695982, "pmcid": "PMC10713140", "title": "Effect of Metformin Versus Placebo on New Primary Cancers in Canadian Cancer Trials Group MA.32: A Secondary Analysis of a Phase III Randomized Double-Blind Trial in Early Breast Cancer", "journal": "J Clin Oncol", "authors": ["Goodwin PJ", "Chen BE", "Gelmon KA", "Whelan TJ", "Ennis M", "Lemieux J", "Ligibel JA", "Hershman DL", "Mayer IA", "Hobday TJ", "Bliss JM", "Rastogi P", "Rabaglio-Poretti M", "Thompson AM", "Rea DW", "Stos PM", "Shepherd LE", "Stambolic V", "Parulekar WR"], "date": "2023-09-11T00:00:00Z", "doi": "10.1200/JCO.23.00296", "meta_date_publication": "2023 Sep 11", "meta_volume": "", "meta_issue": "", "meta_pages": "JCO2300296", "score": 50246.305, "text_hl": "Between 2010 and 2013, 3,649 @SPECIES_9606 @@@patients@@@ with @DISEASE_Breast_Neoplasms @DISEASE_MESH:D001943 @@@breast cancer@@@ younger than 75 years without @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@ with high-risk @<m>DISEASE_Nemaline_myopathy_5</m> @DISEASE_MESH:C538397 @@@T1@@@-3, @DISEASE_Hypomagnesemia_primary @DISEASE_MESH:C537153 @@@N0-3@@@ M0 @DISEASE_Breast_Neoplasms @DISEASE_MESH:D001943 @@@breast cancer@@@ (any @GENE_ESR1 @GENE_2099 @@@estrogen receptor@@@, @GENE_PGR @GENE_5241 @@@progesterone receptor@@@, @GENE_ERBB2 @GENE_2064 @@@human epidermal growth factor receptor 2@@@) were randomly assigned to @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ 850 mg orally twice a day or placebo twice a day for 5 years. ", "citations": {"NLM": "Goodwin PJ, Chen BE, Gelmon KA, Whelan TJ, Ennis M, Lemieux J, Ligibel JA, Hershman DL, Mayer IA, Hobday TJ, Bliss JM, Rastogi P, Rabaglio-Poretti M, Thompson AM, Rea DW, Stos PM, Shepherd LE, Stambolic V, Parulekar WR. Effect of Metformin Versus Placebo on New Primary Cancers in Canadian Cancer Trials Group MA.32: A Secondary Analysis of a Phase III Randomized Double-Blind Trial in Early Breast Cancer J Clin Oncol. 2023 Sep 11;():JCO2300296. PMID: 37695982", "BibTeX": "@article{37695982, title={Effect of Metformin Versus Placebo on New Primary Cancers in Canadian Cancer Trials Group MA.32: A Secondary Analysis of a Phase III Randomized Double-Blind Trial in Early Breast Cancer}, author={Goodwin PJ and Chen BE and Gelmon KA and Whelan TJ and Ennis M and Lemieux J and Ligibel JA and Hershman DL and Mayer IA and Hobday TJ and Bliss JM and Rastogi P and Rabaglio-Poretti M and Thompson AM and Rea DW and Stos PM and Shepherd LE and Stambolic V and Parulekar WR}, journal={J Clin Oncol}, pages={JCO2300296}}"}}, {"_id": "22774523", "pmid": 22774523, "title": "[Metformin does not suppress the aromatase expression in breast cancer tissue of patients with concurrent type 2 diabetes].", "journal": "Vopr Onkol", "authors": ["Bershteĭn LM", "Turkevich EA", "Boiarkina MP"], "date": "2012-01-01T00:00:00Z", "meta_date_publication": "2012", "meta_volume": "58", "meta_issue": "2", "meta_pages": "194-8", "score": 50047.727, "text_hl": "By conventional scores method the following values were obtained: 1.31 (pts without @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@), 1.47 (all @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetic@@@ @SPECIES_9606 @@@patients@@@), 2.22 (@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@MF@@@), 1.50 (@CHEMICAL_Sulfonylurea_Compounds @CHEMICAL_MESH:D013453 @@@SU@@@), 1.29 (@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@MF@@@+@CHEMICAL_Sulfonylurea_Compounds @CHEMICAL_MESH:D013453 @@@SU@@@), 1.81 (@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@MF@@@ and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@MF@@@+@CHEMICAL_Sulfonylurea_Compounds @CHEMICAL_MESH:D013453 @@@SU@@@), 1.07 (diet). ", "citations": {"NLM": "Bershteĭn LM, Turkevich EA, Boiarkina MP. [Metformin does not suppress the aromatase expression in breast cancer tissue of patients with concurrent type 2 diabetes]. Vopr Onkol. 2012;58(2):194-8. PMID: 22774523", "BibTeX": "@article{22774523, title={[Metformin does not suppress the aromatase expression in breast cancer tissue of patients with concurrent type 2 diabetes].}, author={Bershteĭn LM and Turkevich EA and Boiarkina MP}, journal={Vopr Onkol}, volume={58}, number={2}, pages={194-8}}"}}]}